Continuous beta-lactam infusion in critically ill patients: the clinical evidence
There is controversy over whether traditional intermittent bolus dosing or continuous infusion of beta-lactam antibiotics is preferable in critically ill patients. No significant difference between these two dosing strategies in terms of patient outcomes has been shown yet. This is despite compellin...
Main Authors: | Abdul Aziz, Mohd. Hafiz, Dulhunty, Joel M., Bellomo, Rinaldo, Lipman, Jeffrey, Roberts, Jason A. |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer-Verlag Berlin Heidelberg
2012
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/2/2110-5820-2-37.pdf |
Similar Items
-
Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials
by: Roberts, Jason A., et al.
Published: (2016) -
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2016) -
The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2013) -
Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2017) -
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomized controlled trial of continuous infusion versus intermittent bolus administration
by: Jamal, Janattul-Ain, et al.
Published: (2015)